(Total Views: 92)
Posted On: 04/05/2019 9:55:40 AM
Post# of 85725

$TROV News Article - Trovagene Announces Update to Phase 1b/2 AML Trial Data Presented at AACR - Additional Patients Achieve Complete Response at Two Highest Dose Levels of Onvansertib https://marketwirenews.com/news-releases/trov...51256.html


My Twitter: WhyteStocks